Get the Stockscreener App
0.28
4.31%
-0.0126
After Hours:
.27
-0.01
-3.57%
Klotho Neurosciences Inc stock is traded at $0.28, with a volume of 50,380.
It is down -4.31% in the last 24 hours and down -24.12% over the past month.
Klotho Neurosciences Inc is in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders.
See More
Previous Close:
$0.2926
Open:
$0.2831
24h Volume:
50,380
Relative Volume:
0.07
Market Cap:
$7.58M
Revenue:
-
Net Income/Loss:
$-4.23M
P/E Ratio:
-1.3283
EPS:
-0.2108
Net Cash Flow:
-
1W Performance:
-3.88%
1M Performance:
-24.12%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.28
$0.2963
1-Week Range:
$0.2626
$0.31
52-Week Range:
$0.26
$0.9473
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Name
Klotho Neurosciences Inc
Sector
Industry
Phone
646-916-5315
Address
1115 BROADWAY, NEW YORK
Compare KLTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.28 | 7.58M | 0 | -4.23M | 0 | -0.2108 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
Klotho Neurosciences Inc Stock (KLTO) Latest News
Pre-market Movers: BTAI, VRPX, DCGO, NBY... - RTTNews
Klotho Neurosciences faces Nasdaq delisting By Investing.com - Investing.com Australia
Klotho Neurosciences faces Nasdaq delisting - Investing.com India
Citigroup Begins Coverage on Candel Therapeutics (NASDAQ:CADL) - Defense World
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Critical Comparison: Klotho Neurosciences (NASDAQ:KLTO) versus IN8bio (NASDAQ:INAB) - Defense World
Klotho Neurosciences, Inc. announced that it expects to receive $2 million in funding -January 22, 2025 - Marketscreener.com
Klotho Neurosciences secures $2M in convertible notes and warrants By Investing.com - Investing.com Canada
Klotho Neurosciences secures $2M in convertible notes and warrants - Investing.com India
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco - The Manila Times
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Head to Head Contrast: Klotho Neurosciences (NASDAQ:KLTO) & ImmunityBio (NASDAQ:IBRX) - Defense World
Klotho Neurosciences, Inc. announced that it has received $1 million in funding from ACM Projektentwicklung GmbH - Marketscreener.com
Klotho Neurosciences secures $1.2 million convertible note By Investing.com - Investing.com Canada
Klotho Neurosciences secures $1.2 million convertible note - Investing.com India
Klotho Neurosciences, Inc. Appoints Dr. Merit Cudkowicz to Scientific Advisory Board - Marketscreener.com
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences' Scientific Advisory Board - The Manila Times
Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts - GlobeNewswire
Dr. Merit Cudkowicz, Renowned ALS Expert at Massachusetts General Hospital (MGH), Joins Klotho Neurosciences’ Scientific Advisory Board - Yahoo Finance
Former Merck USA President Joins Klotho Neurosciences' Board of Directors - The Manila Times
Former Merck USA President Joins Klotho Neurosciences’ Board of Directors - GlobeNewswire
Klotho Neurosciences Taps Former Merck US President Who Led $12B Portfolio to Board of Directors - StockTitan
Riad El-Dada Joins Klotho Neurosciences’ Board of Directors - citybiz
Klotho Neurosciences expands Board with seasoned healthcare executive By Investing.com - Investing.com Canada
Klotho Neurosciences expands Board with seasoned healthcare executive - Investing.com
Klotho Neurosciences, Inc. and Teleost Biopharmaceuticals, LLC Terminate Licensing Agreement - Marketscreener.com
Terns Pharmaceuticals (TERN) Stock Drops Over 5% Amidst Mixed In - GuruFocus.com
Klotho Neurosciences Inc. (KLTO) reports earnings - Quartzy
Klotho Neurosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Klotho Neurosciences Ends Licensing Agreement with Teleost - TipRanks
Klotho Neurosciences CEO secures new three-year contract By Investing.com - Investing.com Australia
KLTO stock touches 52-week low at $0.39 amid market challenges - Investing.com
Klotho Neurosciences announces accounting firm change - Investing.com India
Klotho Neurosciences CEO secures new three-year contract - Investing.com India
Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor - GlobeNewswire
Klotho Neurosciences faces Nasdaq delisting over share price - Investing.com India
Klotho Neurosciences faces Nasdaq delisting over share price By Investing.com - Investing.com UK
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - Benzinga
Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences - GlobeNewswire
Maravai Lifesciences (MRVI) Stock Surges Over 5% Amid Strong Buy Recommendations - GuruFocus.com
Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket - Benzinga
Klotho Neurosciences Inc Stock (KLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):